Please use this identifier to cite or link to this item:
Title: Serotonin involvement in the basal ganglia pathophysiology : could the 5-HT2C receptor be a new target for therapeutic strategies?
Authors: Di Giovanni, Giuseppe
Di Matteo, Vincenzo
Pierucci, Massimo
Benigno, Arcangelo
Esposito, Ennio
Keywords: Receptor, Serotonin, 5-HT2C
Basal ganglia
Serotonin -- Physiological effect
Serotonin agents
Issue Date: 2006
Publisher: Bentham Science Publishers Ltd.
Citation: Di Giovanni, G., Di Matteo, V., Pierucci, M., Benigno, A., & Esposito, E. (2006). Serotonin involvement in the basal ganglia pathophysiology : could the 5-HT2C receptor be a new target for therapeutic strategies?. Current Medicinal Chemistry, 13(25), 3069-3081.
Abstract: The basal ganglia are a highly interconnected group of subcortical nuclei in the vertebrate brain that play a critical role not only in the control of movements but also in some cognitive and behavioral functions. Several recent studies have emphasized that serotonergic pathways in the central nervous system (CNS) are intimately involved in the modulation of the basal ganglia and in the pathophysiology of human involuntary movement disorders. These observations are supported by anatomical evidence demonstrating large serotonergic innervation of the basal ganglia. In fact, serotonergic terminals have been reported to make synaptic contacts with dopamine (DA)-containing neurons and gamma-aminobutyric acid (GABA)-containing neurons in the striatum, globus pallidus, subthalamus and substantia nigra. These brain areas contain the highest concentration of serotonin (5-HT), with the substantia nigra pars reticulata receiving the greatest input. Furthermore, in these structures a high expression of 5-HT different receptor subtypes has been revealed. In this paper, evidence demonstrating the serotonergic control of basal ganglia functions will be reviewed, focusing on the role of the 5-HT2C receptor subtype. In addition, the involvement of 5-HT2C receptors in neurological disorders such as Parkinson's disease and other related motor disorders, and their management with drugs blocking the 5-HT2C receptor will be discussed.
Appears in Collections:Scholarly Works - FacM&SPB

Files in This Item:
File Description SizeFormat 
Serotonin Involvement in the Basal Ganglia Pathophysiology.pdf
  Restricted Access
215.56 kBAdobe PDFView/Open Request a copy

Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.